AAP
ANIK icon

Arax Advisory Partners’s Anika Therapeutics ANIK Stock Holding History

Arax Advisory Partners’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.67K Buy
322
+36
+13% +$418 ﹤0.01% 2815
2025
Q4 		$2.75K Sell
286
-2,251
-89% -$21.6K ﹤0.01% 3138
2025
Q3 		$23.8K Buy
2,537
+2,229
+724% +$21.3K ﹤0.01% 2186
2025
Q2 		$3.26K Buy
+308
New +$3.89K ﹤0.01% 2390
2024
Q4 		– Sell
-94
Closed -$2.32K – 2444
2024
Q3 		$2.32K Hold
94
– – ﹤0.01% 2009
2024
Q2 		$2.38K Buy
+94
New +$2.44K ﹤0.01% 1901

Other funds holding ANIK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return